吡利啶结构式
|
常用名 | 吡利啶 | 英文名 | Meperidine Hydrochloride |
|---|---|---|---|---|
| CAS号 | 50-13-5 | 分子量 | 283.79400 | |
| 密度 | 1.0858 | 沸点 | 282°C | |
| 分子式 | C15H22ClNO2 | 熔点 | 186-189° | |
| MSDS | 中文版 美版 | 闪点 | 11 °C | |
| 符号 |
GHS06 |
信号词 | Danger |
| 中文名 | 吡利啶 |
|---|---|
| 英文名 | ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,hydrochloride |
| 中文别名 | 哌替啶盐酸盐 |
| 英文别名 | 更多 |
| 密度 | 1.0858 |
|---|---|
| 沸点 | 282°C |
| 熔点 | 186-189° |
| 分子式 | C15H22ClNO2 |
| 分子量 | 283.79400 |
| 闪点 | 11 °C |
| 精确质量 | 283.13400 |
| PSA | 29.54000 |
| LogP | 2.95300 |
| 折射率 | 1.5200 |
| 储存条件 | 2-8°C |
| 水溶解性 | Very soluble in water, freely soluble in alcohol. |
| 符号 |
GHS06 |
|---|---|
| 信号词 | Danger |
| 危害声明 | H301 |
| 警示性声明 | P301 + P310 |
| 个人防护装备 | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| 危害码 (欧洲) | T,F |
| 风险声明 (欧洲) | 25-39/23/24/25-23/24/25-11 |
| 安全声明 (欧洲) | 26-36/37/39-45-36/37-16-7 |
| 危险品运输编码 | UN 1544 |
| RTECS号 | NS5950000 |
| 包装等级 | III |
| 危险类别 | 6.1(b) |
|
~45%
吡利啶 50-13-5 |
| 文献:AUSPEX PHARMACEUTICALS, INC. Patent: US2011/160244 A1, 2011 ; Location in patent: Page/Page column 11 ; US 20110160244 A1 |
|
~%
吡利啶 50-13-5 |
| 文献:AUSPEX PHARMACEUTICALS, INC. Patent: US2011/160244 A1, 2011 ; US 20110160244 A1 |
| 吡利啶上游产品 2 | |
|---|---|
| 吡利啶下游产品 0 | |
|
Salt effects in electromembrane extraction.
J. Chromatogr. A. 1347 , 1-7, (2014) Electromembrane extraction (EME) was performed on samples containing substantial amounts of NaCl to investigate how the presence of salts affected the recovery, repeatability, and membrane current in ... |
|
|
Identification and quantification of 34 drugs and toxic compounds in blood, urine, and gastric content using liquid chromatography with tandem mass spectrometry.
J. Sep. Sci. 38 , 1680-90, (2015) A liquid chromatography with tandem mass spectrometry method was developed for the simultaneous screening of 34 drugs and poisons in forensic cases. Blood (0.5 mL, diluted 1:1 with water) or 1.0 mL of... |
|
|
Temperature management in haematology patients with febrile neutropenia: a practice survey.
N. Z. Med. J. 126(1373) , 62-73, (2013) To assess the attitudes of clinicians to temperature management in haematology patients with febrile neutropenia.An online scenario-based survey was circulated to consultant members of the New Zealand... |
| pethidine hydrochloride |
| 1-Methyl-4-phenyl-piperidin-4-carbonsaeure-aethylester,Hydrochlorid |
| Dolantal |
| Antiduol |
| Dispadol |
| Dolestine |
| Meperidine Hydrochloride |
| Algil |
| Chlorbycyclen |
| Centralgin |
| meperidine HCl |
| Dolantin |
| 1-methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester,hydrochloride |
| Dolargan |
| Dolaren |